Russell Alan J
SEC insider (Form 3/4/5 filer). CIK 0001853529. Chief Scientific Officer at Edgewise Therapeutics, Inc. (EWTX). 33 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOULDER, CO.
Companies Russell Alan J has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Director, Officer, Chief Scientific Officer
Russell Alan J
CIK: 0001853529
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edgewise Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (33 total)
- Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect7K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect3.2K shares at avg. $43.68$141K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
65K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect390 shares at avg. $44.46$17K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.3K shares at avg. $43.68$99K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
32.5K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect5.8K shares- - Jul 1, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect69.6K shares at avg. $39.41$2.7M - Jul 1, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect130.4K shares at avg. $0.45$59K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 7,031 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 3,238 | $43.68 | $141,428 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 65,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 390 | $44.46 | $17,339 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,273 | $43.68 | $99,275 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 32,500 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 5,781 | - | $0 | Direct |
| Jul 1, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 69,648 | $39.41 | $2,744,751 | Direct |
| Jul 1, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 130,352 | $0.45 | $58,658 | Direct |
1-10 of 33 transactions